World Health Organization Raises Alert Over Critical Lack of Weight-Loss Injections

Less than one in 10 patients eligible to benefit from weight-loss injections including Wegovy are able to get them, states the WHO as it releases its first guidance on the drugs.

Given in excess of 1,000,000,000 individuals worldwide now obese, it is advocating for more widespread and fairer access to GLP-1 medication.

Based on estimates, more than two billion are projected to be obese by 2030 without intervention.

"Our new guidance recognises that excess weight is a long-term condition that can be treated with comprehensive and continuous support," said WHO director-general Tedros Adhanom Ghebreyesus.

Significant expense, insufficient output, and distribution challenges are significant obstacles to broad availability to the injections that can assist patients in reducing significant body mass, says the agency.

Weight-Loss Drug Scarcity

Even in the present most favorable case, the supply of these medications might only reach around 100 million people – under 10% of the global need, as stated by the WHO.

The recommendation calls on nations and manufacturers to widen access, via strategies such as patent sharing.

A patent on the active ingredient – the primary ingredient of a leading brand – is scheduled to end in a number of countries in 2026.

The Way Weight-Loss Injections Work

The injections mimick a biological compound to delay gastric emptying, suppress the appetite and increase feelings of fullness so people eat less.

Patients typically see weight reduction in the initial weeks of starting on the once-weekly jabs.

Evidence points to users may put most of the weight back on within a year of halting the treatment, because their typical food cravings return.

Being above a healthy weight elevates your chance for contracting health problems, such as type 2 diabetes, heart disease, stroke, and some malignancies.

Excess weight impacts individuals in all nations and was linked to 3.7 million fatalities worldwide in 2024, according to the health agency.

Jessica Fowler
Jessica Fowler

A seasoned gaming journalist with over a decade of experience covering esports and industry trends across Europe.